{"id":"https://openalex.org/W2883048337","doi":"https://doi.org/10.1016/j.critrevonc.2018.07.002","title":"Concern over cost of and access to cancer treatments: A meta-narrative review of nivolumab and pembrolizumab studies","display_name":"Concern over cost of and access to cancer treatments: A meta-narrative review of nivolumab and pembrolizumab studies","publication_year":2018,"publication_date":"2018-07-17","ids":{"openalex":"https://openalex.org/W2883048337","doi":"https://doi.org/10.1016/j.critrevonc.2018.07.002","mag":"2883048337","pmid":"https://pubmed.ncbi.nlm.nih.gov/30097232"},"language":"en","primary_location":{"id":"doi:10.1016/j.critrevonc.2018.07.002","doi":"https://doi.org/10.1016/j.critrevonc.2018.07.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2018.07.002","pdf_url":null,"source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029684509","display_name":"C\u00e1ssia Rita Pereira da Veiga","orcid":"https://orcid.org/0000-0002-9219-6279","observed_orcids":["https://orcid.org/0000-0002-9219-6279"]},"institutions":[{"id":"https://openalex.org/I176838256","display_name":"Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1","ror":"https://ror.org/02x1vjk79","country_code":"BR","type":"education","lineage":["https://openalex.org/I176838256"]},{"id":"https://openalex.org/I52418104","display_name":"Universidade Federal do Paran\u00e1","ror":"https://ror.org/05syd6y78","country_code":"BR","type":"education","lineage":["https://openalex.org/I52418104"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"C\u00e1ssia Rita Pereira da Veiga","raw_affiliation_strings":["Business School Postgraduate Program (PPAD), Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1 (PUCPR), Imaculada Concei\u00e7\u00e3o, 1155, 80215-901, Curitiba, PR, Brazil","School of Management, Universidade Federal do Paran\u00e1 (UFPR), 632 Loth\u00e1rio Meissner Ave, Jardim Bot\u00e2nico, 80210-170, Curitiba, PR, Brazil. Electronic address: claudimar.veiga@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Business School Postgraduate Program (PPAD), Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1 (PUCPR), Imaculada Concei\u00e7\u00e3o, 1155, 80215-901, Curitiba, PR, Brazil","institution_ids":["https://openalex.org/I176838256"]},{"raw_affiliation_string":"School of Management, Universidade Federal do Paran\u00e1 (UFPR), 632 Loth\u00e1rio Meissner Ave, Jardim Bot\u00e2nico, 80210-170, Curitiba, PR, Brazil. Electronic address: claudimar.veiga@gmail.com","institution_ids":["https://openalex.org/I52418104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075607616","display_name":"Claudimar Pereira da Veiga","orcid":"https://orcid.org/0000-0002-4960-5954","observed_orcids":["https://orcid.org/0000-0002-4960-5954"]},"institutions":[{"id":"https://openalex.org/I176838256","display_name":"Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1","ror":"https://ror.org/02x1vjk79","country_code":"BR","type":"education","lineage":["https://openalex.org/I176838256"]},{"id":"https://openalex.org/I52418104","display_name":"Universidade Federal do Paran\u00e1","ror":"https://ror.org/05syd6y78","country_code":"BR","type":"education","lineage":["https://openalex.org/I52418104"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Claudimar Pereira da Veiga","raw_affiliation_strings":["Business School Postgraduate Program (PPAD), Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1 (PUCPR), Imaculada Concei\u00e7\u00e3o, 1155, 80215-901, Curitiba, PR, Brazil","School of Management, Universidade Federal do Paran\u00e1 (UFPR), 632 Loth\u00e1rio Meissner Ave, Jardim Bot\u00e2nico, 80210-170, Curitiba, PR, Brazil. Electronic address: claudimar.veiga@gmail.com","School of Management, Universidade Federal do Paran\u00e1 (UFPR), 632 Loth\u00e1rio Meissner Ave, Jardim Bot\u00e2nico, 80210-170, Curitiba, PR, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Business School Postgraduate Program (PPAD), Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1 (PUCPR), Imaculada Concei\u00e7\u00e3o, 1155, 80215-901, Curitiba, PR, Brazil","institution_ids":["https://openalex.org/I176838256"]},{"raw_affiliation_string":"School of Management, Universidade Federal do Paran\u00e1 (UFPR), 632 Loth\u00e1rio Meissner Ave, Jardim Bot\u00e2nico, 80210-170, Curitiba, PR, Brazil. Electronic address: claudimar.veiga@gmail.com","institution_ids":["https://openalex.org/I52418104"]},{"raw_affiliation_string":"School of Management, Universidade Federal do Paran\u00e1 (UFPR), 632 Loth\u00e1rio Meissner Ave, Jardim Bot\u00e2nico, 80210-170, Curitiba, PR, Brazil","institution_ids":["https://openalex.org/I52418104"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066855937","display_name":"Ana Paula Drummond\u2010Lage","orcid":"https://orcid.org/0000-0003-0289-8953","observed_orcids":["https://orcid.org/0000-0003-0289-8953"]},"institutions":[{"id":"https://openalex.org/I4210107309","display_name":"Faculdade de Ci\u00eancias M\u00e9dicas de Minas Gerais","ror":"https://ror.org/01p7p3890","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210107309"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ana Paula Drummond-Lage","raw_affiliation_strings":["Faculty of Medical Sciences of Minas Gerais, Alameda Ezequiel Dias, 275, 30130- 110, Belo Horizonte, MG, Brazil"],"raw_orcid":"https://orcid.org/0000-0003-0289-8953","affiliations":[{"raw_affiliation_string":"Faculty of Medical Sciences of Minas Gerais, Alameda Ezequiel Dias, 275, 30130- 110, Belo Horizonte, MG, Brazil","institution_ids":["https://openalex.org/I4210107309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5075607616"],"corresponding_institution_ids":["https://openalex.org/I176838256","https://openalex.org/I52418104"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":1.0665,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.75525813,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"129","issue":null,"first_page":"133","last_page":"145"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.8579000234603882,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.8579000234603882,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.08609999716281891,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.031099999323487282,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7730000019073486},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cancer-treatment-costs","display_name":"cancer treatment costs","score":0.7369999885559082},{"id":"https://openalex.org/keywords/access-to-cancer-treatment","display_name":"access to cancer treatment","score":0.8809999823570251},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.925000011920929},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7620000243186951},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/pharmacoeconomic-evaluation","display_name":"pharmacoeconomic evaluation","score":0.8119999766349792},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.39899998903274536},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8579835891723633},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8119632005691528},{"id":"https://openalex.org/C199033989","wikidata":"https://www.wikidata.org/wiki/Q1318295","display_name":"Narrative","level":2,"score":0.5865913033485413},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5099047422409058},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.4739297032356262},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.4489554166793823},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.37195566296577454},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32755380868911743},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.28386378288269043},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23383155465126038},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23309123516082764},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.15059736371040344},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.13027331233024597},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10705435276031494},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000600","qualifier_name":"supply & distribution","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006297","descriptor_name":"Health Services Accessibility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.critrevonc.2018.07.002","doi":"https://doi.org/10.1016/j.critrevonc.2018.07.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2018.07.002","pdf_url":null,"source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},{"id":"pmid:30097232","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30097232","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical reviews in oncology/hematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":131,"referenced_works":["https://openalex.org/W1572267688","https://openalex.org/W1588865653","https://openalex.org/W1711637573","https://openalex.org/W1757407923","https://openalex.org/W1915698186","https://openalex.org/W2050056063","https://openalex.org/W2063264144","https://openalex.org/W2066480210","https://openalex.org/W2083085858","https://openalex.org/W2089572944","https://openalex.org/W2096815108","https://openalex.org/W2102813375","https://openalex.org/W2104347254","https://openalex.org/W2107038014","https://openalex.org/W2112121482","https://openalex.org/W2120109270","https://openalex.org/W2131969130","https://openalex.org/W2132066361","https://openalex.org/W2134119471","https://openalex.org/W2139655017","https://openalex.org/W2143401180","https://openalex.org/W2152881011","https://openalex.org/W2152897456","https://openalex.org/W2156353875","https://openalex.org/W2162253525","https://openalex.org/W2166991740","https://openalex.org/W2181792533","https://openalex.org/W2198093519","https://openalex.org/W2210073947","https://openalex.org/W2211426731","https://openalex.org/W2212551923","https://openalex.org/W2220868592","https://openalex.org/W2222086386","https://openalex.org/W2225138394","https://openalex.org/W2227542431","https://openalex.org/W2259307740","https://openalex.org/W2264465777","https://openalex.org/W2265758380","https://openalex.org/W2273267066","https://openalex.org/W2282441333","https://openalex.org/W2287821501","https://openalex.org/W2290111006","https://openalex.org/W2310252196","https://openalex.org/W2317857465","https://openalex.org/W2344907503","https://openalex.org/W2347297735","https://openalex.org/W2360584240","https://openalex.org/W2386040222","https://openalex.org/W2396671137","https://openalex.org/W2396870225","https://openalex.org/W2397716952","https://openalex.org/W2398024575","https://openalex.org/W2399924257","https://openalex.org/W2400521313","https://openalex.org/W2403502589","https://openalex.org/W2404542580","https://openalex.org/W2408272664","https://openalex.org/W2410849341","https://openalex.org/W2412670937","https://openalex.org/W2425252308","https://openalex.org/W2462584358","https://openalex.org/W2462875986","https://openalex.org/W2465704811","https://openalex.org/W2469601491","https://openalex.org/W2470100784","https://openalex.org/W2481017087","https://openalex.org/W2495067315","https://openalex.org/W2500441301","https://openalex.org/W2501014534","https://openalex.org/W2507396986","https://openalex.org/W2509848114","https://openalex.org/W2512123923","https://openalex.org/W2516652195","https://openalex.org/W2517323327","https://openalex.org/W2518261154","https://openalex.org/W2518317522","https://openalex.org/W2519173444","https://openalex.org/W2520877290","https://openalex.org/W2523066525","https://openalex.org/W2523268772","https://openalex.org/W2528475320","https://openalex.org/W2528848515","https://openalex.org/W2534538480","https://openalex.org/W2536172562","https://openalex.org/W2540154841","https://openalex.org/W2540772623","https://openalex.org/W2542147719","https://openalex.org/W2542375051","https://openalex.org/W2542499666","https://openalex.org/W2542713996","https://openalex.org/W2542885621","https://openalex.org/W2543257443","https://openalex.org/W2543429373","https://openalex.org/W2543547041","https://openalex.org/W2543610804","https://openalex.org/W2543620964","https://openalex.org/W2543987631","https://openalex.org/W2544470319","https://openalex.org/W2544987467","https://openalex.org/W2545154472","https://openalex.org/W2545174563","https://openalex.org/W2545228523","https://openalex.org/W2545285262","https://openalex.org/W2545574478","https://openalex.org/W2545577308","https://openalex.org/W2545982353","https://openalex.org/W2548517655","https://openalex.org/W2554808068","https://openalex.org/W2568704677","https://openalex.org/W2569744812","https://openalex.org/W2570437029","https://openalex.org/W2570570568","https://openalex.org/W2570612628","https://openalex.org/W2571329859","https://openalex.org/W2586467896","https://openalex.org/W2587740019","https://openalex.org/W2588278598","https://openalex.org/W2754051097","https://openalex.org/W2768600953","https://openalex.org/W2788428060","https://openalex.org/W2890324186","https://openalex.org/W2890579681","https://openalex.org/W2891759144","https://openalex.org/W3013867597","https://openalex.org/W4230244612","https://openalex.org/W4237417153","https://openalex.org/W4241258982","https://openalex.org/W4247210542","https://openalex.org/W6724131641","https://openalex.org/W6725880191","https://openalex.org/W6733020015"],"related_works":["https://openalex.org/W2519173444","https://openalex.org/W2410849341","https://openalex.org/W4246227437","https://openalex.org/W4256168913","https://openalex.org/W2894327635","https://openalex.org/W2972154002","https://openalex.org/W2570437029","https://openalex.org/W4237824022","https://openalex.org/W4293569275","https://openalex.org/W4417120847"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-08-03T00:00:00"}